Therapy with voretigene neparvovec. How to measure success?
2022 · Progress in Retinal and Eye Research · 45 citations
https://doi.org/10.1016/j.preteyeres.2022.101115
STZ eyetrial(DE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
12
Papers
66
Citations
3
h-index
1
i10-index
Milda Reith is an academic researcher from STZ eyetrial. The author has contributed to research in topics: Retinal Development and Disorders & Retinal Diseases and Treatments & Retinal and Optic Conditions. The author has an h-index of 3, co-authored 11 publications.
ORCID: 0000-0003-3656-0707https://doi.org/10.1016/j.preteyeres.2022.101115
https://doi.org/10.1167/iovs.64.11.18
https://doi.org/10.1136/bjo-2023-323747
https://doi.org/10.1111/aos.15765
https://doi.org/10.1167/tvst.13.4.23
Click to start Chat